Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.23.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 128 $ 47,803,643 $ (41,499,522) $ 6,304,249
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 17,309,187      
Issuance of common stock for public offering, net of issuance costs of $1,910,816 $ 67 18,089,117 18,089,184
Issuance of common stock for public offering, net of issuance costs, shares 6,666,667      
Issuance of common stock for exercise of warrants
Issuance of common stock for exercise of warrants, shares 6,247      
Issuance of common stock for exercise of stock options and restricted shares 15,000 15,000
Issuance of common stock for exercise of stock options and restricted shares, shares 82,520      
Stock-based compensation 1,575,165 1,575,165
Stock-based compensation, shares 44,623      
Net loss (8,612,345) (8,612,345)
Ending balance, value at Mar. 31, 2022 $ 195 67,482,925 (50,111,867) 17,371,253
Shares, Outstanding, Ending Balance at Mar. 31, 2022 24,109,244      
Beginning balance, value at Dec. 31, 2022 $ 198 76,369,742 (75,734,927) 635,013
Shares, Outstanding, Beginning Balance at Dec. 31, 2022 24,426,260      
Issuance of common stock for exercise of stock options and restricted shares $ 1 24,999 25,000
Issuance of common stock for exercise of stock options and restricted shares, shares 50,000      
Stock-based compensation $ 1 1,057,434 1,057,435
Stock-based compensation, shares 138,859      
Net loss (7,299,469) (7,299,469)
Ending balance, value at Mar. 31, 2023 $ 200 $ 77,452,175 $ (83,034,396) $ (5,582,021)
Shares, Outstanding, Ending Balance at Mar. 31, 2023 24,615,119